These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8707926)

  • 41. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain-Barré syndrome.
    Péter M; Török W; Petrovics-Balog A; Vígh L; Vécsei L; Balogh G
    Sci Rep; 2020 Oct; 10(1):18380. PubMed ID: 33110173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.
    Segurado OG; Krüger H; Mertens HG
    J Neurol; 1986 Aug; 233(4):202-8. PubMed ID: 3746360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome.
    Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
    J Neurol Sci; 2014 May; 340(1-2):37-43. PubMed ID: 24607336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A study on red blood cell immune function in patients with Guillain-Barré syndrome and multiple sclerosis].
    Qi X; Zhu K; Liu J
    Zhonghua Nei Ke Za Zhi; 1996 Aug; 35(8):517-9. PubMed ID: 9594140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channels.
    Würz A; Brinkmeier H; Wollinsky KH; Mehrkens HH; Kornhuber HH; Rüdel R
    Muscle Nerve; 1995 Jul; 18(7):772-81. PubMed ID: 7783768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in free amino acids of cerebrospinal fluid and plasma in various neurological diseases.
    Iijima K; Takase S; Tsumuraya K; Endo M; Itahara K
    Tohoku J Exp Med; 1978 Oct; 126(2):133-50. PubMed ID: 715764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseases.
    Sanders ME; Alexander EL; Koski CL; Shin ML; Sano Y; Frank MM; Joiner KA
    Ann N Y Acad Sci; 1988; 540():387-8. PubMed ID: 3207265
    [No Abstract]   [Full Text] [Related]  

  • 51. The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid.
    Brinkmeier H; Wollinsky KH; Hülser PJ; Seewald MJ; Mehrkens HH; Kornhuber HH; Rüdel R
    Pflugers Arch; 1992 Sep; 421(6):552-7. PubMed ID: 1331974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome.
    Koski CL
    Ann Neurol; 1990; 27 Suppl():S44-7. PubMed ID: 2194426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
    Novakova L; Zetterberg H; Sundström P; Axelsson M; Khademi M; Gunnarsson M; Malmeström C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
    Neurology; 2017 Nov; 89(22):2230-2237. PubMed ID: 29079686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Bartosik-Psujek H; Stelmasiak Z
    J Neural Transm (Vienna); 2005 Jun; 112(6):797-803. PubMed ID: 15480850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated haptoglobin level of cerebrospinal fluid in Guillain-Barré syndrome revealed by proteomics analysis.
    Chang KH; Lyu RK; Tseng MY; Ro LS; Wu YR; Chang HS; Hsu WC; Kuo HC; Huang CC; Chu CC; Hsieh SY; Chen CM
    Proteomics Clin Appl; 2007 May; 1(5):467-75. PubMed ID: 21136698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A potential role for human herpesvirus type 6 in nervous system disease.
    Wilborn F; Schmidt CA; Brinkmann V; Jendroska K; Oettle H; Siegert W
    J Neuroimmunol; 1994 Jan; 49(1-2):213-4. PubMed ID: 8294559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.
    Pascual M; Duchosal MA; Steiger G; Giostra E; Pechère A; Paccaud JP; Danielsson C; Schifferli JA
    J Immunol; 1993 Aug; 151(3):1702-11. PubMed ID: 8335953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormalities of cerebrospinal fluid amino acids in patients with the Guillain-Barré syndrome.
    Corston RN; McGale EH; Stonier C; Aber GM; Hutchinson EC
    J Neurol Neurosurg Psychiatry; 1981 Jan; 44(1):86-9. PubMed ID: 7205311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases.
    Di Bona D; Montalto G; Clemenza L; Bascone F; Accardo P; Bellavia D; Craxì A; Brai M
    Clin Exp Immunol; 1998 Oct; 114(1):102-5. PubMed ID: 9764610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
    Lindblom RP; Aeinehband S; Ström M; Al Nimer F; Sandholm K; Khademi M; Nilsson B; Piehl F; Ekdahl KN
    Clin Immunol; 2016 May; 166-167():89-95. PubMed ID: 27085202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.